EP0939761A4 - Salmonella sekretierte proteine und verwendung davon - Google Patents

Salmonella sekretierte proteine und verwendung davon

Info

Publication number
EP0939761A4
EP0939761A4 EP96940523A EP96940523A EP0939761A4 EP 0939761 A4 EP0939761 A4 EP 0939761A4 EP 96940523 A EP96940523 A EP 96940523A EP 96940523 A EP96940523 A EP 96940523A EP 0939761 A4 EP0939761 A4 EP 0939761A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
salmonella
salmonella secreted
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96940523A
Other languages
English (en)
French (fr)
Other versions
EP0939761A1 (de
Inventor
Samuel I Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of EP0939761A1 publication Critical patent/EP0939761A1/de
Publication of EP0939761A4 publication Critical patent/EP0939761A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EP96940523A 1995-11-14 1996-11-14 Salmonella sekretierte proteine und verwendung davon Withdrawn EP0939761A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US673395P 1995-11-14 1995-11-14
US6733P 1995-11-14
PCT/US1996/018504 WO1997018225A1 (en) 1995-11-14 1996-11-14 Salmonella secreted proteins and uses thereof

Publications (2)

Publication Number Publication Date
EP0939761A1 EP0939761A1 (de) 1999-09-08
EP0939761A4 true EP0939761A4 (de) 2002-07-31

Family

ID=21722306

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96940523A Withdrawn EP0939761A4 (de) 1995-11-14 1996-11-14 Salmonella sekretierte proteine und verwendung davon

Country Status (4)

Country Link
EP (1) EP0939761A4 (de)
AU (1) AU7738396A (de)
CA (1) CA2237581A1 (de)
WO (1) WO1997018225A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060099543A (ko) 1994-12-09 2006-09-19 임페리얼 컬리지 이노베이션스 리미티드 유전자의 동정
US6080849A (en) 1997-09-10 2000-06-27 Vion Pharmaceuticals, Inc. Genetically modified tumor-targeted bacteria with reduced virulence
WO1999013053A1 (en) 1997-09-10 1999-03-18 Vion Pharmaceuticals, Inc. Genetically modified tumor-targeted bacteria with reduced virulence
CA2341349C (en) 1998-09-04 2013-12-10 Creatogen Aktiengesellschaft Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof
GB9910812D0 (en) 1999-05-10 1999-07-07 Microscience Ltd Vaccine composition
US6962696B1 (en) 1999-10-04 2005-11-08 Vion Pharmaceuticals Inc. Compositions and methods for tumor-targeted delivery of effector molecules
US6605285B2 (en) 2000-03-29 2003-08-12 G.B. Pant University Of Agriculture & Technology Vaccine for protection of poultry against salmonellosis and a process for preparing the same
DE102005037796A1 (de) * 2005-08-07 2007-02-08 Tgc Biomics Gmbh Testsystem zum Nachweis von Salmonellen
US7833740B2 (en) 2005-08-07 2010-11-16 Tgc Biomics Gmbh Test system for detecting salmonella
JP2010501599A (ja) * 2006-08-31 2010-01-21 ザ ユニヴァーシティ オブ ブリティッシュ コロンビア 脊椎動物の被験体におけるサルモネラ種細菌感染症の治療または予防のためのワクチンおよび方法
US8703153B2 (en) 2008-06-16 2014-04-22 Prokarium Ltd. Salmonella vectored vaccines against Chlamydia and methods of use
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
DE102010018085A1 (de) * 2010-04-23 2011-10-27 Bioserv Analytik Und Medizinprodukte Gmbh Verfahren zur Erkennung einer Salmonelleninfektion
US10548962B2 (en) 2012-10-22 2020-02-04 The Board Of Regents For Oklahoma State University Use of the salmonella SPP type III secretion proteins as a protective vaccination
US20150238590A1 (en) * 2012-10-22 2015-08-27 The Board Of Regents For Oklahoma State University Use of the salmonella spp type iii secretion proteins as a protective vaccination
US9950053B2 (en) 2012-10-22 2018-04-24 The Board Of Regents For Oklahoma State University Use of the Salmonella SPP type III secretion proteins as a protective vaccination
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695983A (en) * 1990-12-18 1997-12-09 The General Hospital Corporation Salmonella vaccines

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 4 October 1995 (1995-10-04), HERMANT D ET AL: "Functional conservation of the Salmonella and Shigella effectors of entry into epithelial cells." *
DATABASE EMBL 6 September 1995 (1995-09-06), KANIGA K ET AL: "Homologs of the Shigella IpaB and IpaC invasins are required for Salmonella typhimurium entry into cultured epithelial cells." *
HERMANT DANIEL ET AL: "Functional conservation of the Salmonella and Shigella effectors of entry into epithelial cells.", MOLECULAR MICROBIOLOGY, vol. 17, no. 4, 1995, pages 781 - 789, XP001055768, ISSN: 0950-382X *
KANIGA KONE ET AL: "Homologs of the Shigella IpaB and IpaC invasins are required for Salmonella typhimurium entry into cultured epithelial cells.", JOURNAL OF BACTERIOLOGY, vol. 177, no. 14, 1995, pages 3965 - 3971, XP002188881, ISSN: 0021-9193 *
PEGUES DAVID A ET AL: "PhoP/PhoQ transcriptional repression of Salmonella typhimurium invasion genes: Evidence for a role in protein secretion.", MOLECULAR MICROBIOLOGY, vol. 17, no. 1, 1995, pages 169 - 181, XP001034139, ISSN: 0950-382X *
See also references of WO9718225A1 *

Also Published As

Publication number Publication date
AU7738396A (en) 1997-06-05
CA2237581A1 (en) 1997-05-22
EP0939761A1 (de) 1999-09-08
WO1997018225A1 (en) 1997-05-22

Similar Documents

Publication Publication Date Title
EP0785276A4 (de) Modifizierung eines peptids und eines proteins
EP1039801A4 (de) 207 menschliche sekretierte proteine
EP1000084A4 (de) 123 vom menschen abgesonderte proteine
IL122428A0 (en) Minizymes and minribozymes and uses thereof
EP1040117A4 (de) 110 menschliche sekretierte proteines
EP0939761A4 (de) Salmonella sekretierte proteine und verwendung davon
EP1005544A4 (de) 70 menschliche, sekretierte proteine
EP1019091A4 (de) 50 menschliche sekretierte proteine
ZA955225B (en) Crucifer AFT proteins and uses thereof
EP1032838A4 (de) 125 menschliche sekretierte proteine
EP1027430A4 (de) 64 menschliche sekretierte proteine
GB9510830D0 (en) Proteins
EP1009766A4 (de) 19 menschlisch, sekretierte proteine
EP1042674A4 (de) 148 menschliche sekretierte proteine
EP0836617A4 (de) Parevine und tachyteprine
ZA96240B (en) Novel peptides their preparation and use
EP1003763A4 (de) 83 vom menschen freigesetzte proteine
EP1017707A4 (de) 29 menschliche sekretierte proteine
GB9423372D0 (en) Proteins and their uses
EP1019506A4 (de) 101 sekretierte proteine vom menschen.
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
ZA96239B (en) Novel peptides their preparation and use
IL115317A0 (en) Proteins
PL320463A1 (en) Novel pka bonding proteins and their application
GB9519865D0 (en) Protein

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980612

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB

A4 Supplementary search report drawn up and despatched

Effective date: 20020613

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE FR GB

17Q First examination report despatched

Effective date: 20030912

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060601